Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment

NCT00544284 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Brain and Central Nervous System Tumors
Lymphoma
Metastatic Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: bortezomib
DRUG: temozolomide
OTHER: pharmacological study

Sponsor

City of Hope Medical Center

Collaborators

[object Object]